← FDA Drug Approvals (Drugs@FDA)

XOFLUZA

NDA · New Drug Application · Sponsor: GENENTECH INC · Approved 2022-08-11

Drug application

FDA Application #

NDA214410

Application type

New Drug Application

Brand name

XOFLUZA

Generic name

BALOXAVIR MARBOXIL

Active ingredients

BALOXAVIR MARBOXIL

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

GENENTECH INC

Manufacturer

Genentech, Inc.

First approval

2022-08-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown